Erythromycin
- Product NDC
- 63739-053
- 11-digit product format
- 637390053
- Labeler code
- 63739
- Product ID
- 63739-053_c706f1d7-6bdd-41b3-a458-64dc442e355e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- McKesson Corporation
- Application
- ANDA208154
- Marketing category
- ANDA
- Marketing start
- 2020-03-11
- Marketing end
- 0000-00-00
- Substance
- ERYTHROMYCIN
- Active strength
- 20 mg/g
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63739-053-66 | 63739005366 | 1 TUBE in 1 CARTON (63739-053-66) > 30 g in 1 TUBE | 1 tube | 2020-03-11 | 0000-00-00 | No | No | Current |
| 63739-053-68 | 63739005368 | 1 TUBE in 1 CARTON (63739-053-68) > 60 g in 1 TUBE | 1 tube | 2020-03-11 | 0000-00-00 | No | No | Current |